Impact of anticoagulant treatment strategy during initiation of antiarrhythmic drugs on clinical outcomes in atrial fibrillation patients with low CHA2DS2-VASc scores | Synapse
February 28, 2026Open Access
Impact of anticoagulant treatment strategy during initiation of antiarrhythmic drugs on clinical outcomes in atrial fibrillation patients with low CHA2DS2-VASc scores
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.